Starting antiretroviral therapy significantly reduces the risk of decompensated liver disease for men with HIV/HCV co-infection
HIV treatment in South Africa has had "astounding" benefits
Good adherence to HIV treatment, undetectable viral load, reduce the risk of anal infection with high-risk HPV types for MSM with HIV
Severity of HIV seroconversion illness associated with subsequent disease progression
For women, HIV treatment based on atazanavir/ritonavir involves twice the risk of failure compared to efavirenz-containing therapy
Micronutrient supplements delay HIV disease progression for patients with higher CD4 cell counts
Proportion of people in southern Africa starting ART with advanced HIV disease falls
HIV treatment update – the final edition
